U.S. Metals and Mining Stock News

Community Trust Bancorp recently highlighted a quarterly dividend of US$0.53 per share, implying a 3.43% yield and reflecting five consecutive years of annual dividend increases averaging 5.32%. Alongside this dividend profile, the company is guided by a Zacks Consensus Estimate pointing to fiscal 2026 earnings of US$5.79 per share, suggesting investors are closely watching how income and earnings trends align. With this backdrop of consistent dividend growth, we’ll examine how the company’s...

Synopsys (NasdaqGS:SNPS) has appointed Peter A. Shimer, a long time Deloitte executive, to its board of directors and audit committee. The company is not renominating two sitting directors, resulting in a refreshed board composition. Shimer brings extensive financial, operational and AI related governance experience, including work with AI focused cancer research alliances. For investors watching Synopsys at a share price of $414.0, this board change arrives after mixed recent returns. The...

In February 2026, STAAR Surgical announced that the FDA approved an expanded age indication for its EVO/EVO+ Visian Implantable Collamer Lenses, extending U.S. use from ages 21–45 to 21–60 following three-year safety data. This broader label meaningfully enlarges the potential U.S. candidate pool for EVO ICL, especially among adults aged 46–60 who were previously excluded. We’ll now examine how opening EVO ICL access to patients up to age 60 could reshape STAAR Surgical’s longer-term...

Lantheus Holdings (LNTH) just posted fourth quarter results that topped Wall Street expectations on both revenue and earnings, while issuing 2026 guidance that sits below consensus and reflects expected pressure on key products. See our latest analysis for Lantheus Holdings. The latest earnings beat and guidance update come after a sharp rebound in the 3‑month share price return of 27.25% and a 1‑month share price return of 12.97%, even though the 1‑year total shareholder return is still down...

In recent months, Victoria’s Secret raised its full-year net sales outlook and projected improved adjusted operating income, supported by strong international retail sales, particularly in China, as it continued its post-pandemic brand repositioning. Alongside this operational progress, the company has leaned into cultural relevance through the revived Victoria’s Secret Fashion Show and celebrity collaborations to deepen engagement with younger, global consumers. With management’s upgraded...

If you are wondering whether Hinge Health at around US$42.76 is offering good value or asking too much, you are not alone. This article is designed to help you frame that question clearly. Over the short term, the stock has moved, with a 3.5% return over the last 7 days, 13.6% over the last 30 days, and a 6.1% decline year to date. These changes can influence how investors think about both upside and risk. Recent coverage has focused on Hinge Health as a listed digital healthcare name and on...

Healthpeak Properties (DOC) is in focus after confirming that CEO Scott Brinker will speak at the Citi 2026 Global Property CEO Conference, while the company continues work on the Janus Living senior housing REIT IPO. See our latest analysis for Healthpeak Properties. Recent interest around the CEO’s Citi conference appearance and the Janus Living IPO work comes as the stock shows a 1-day share price return of 0.97% and a 7-day share price return of 4.06%. The 1-year total shareholder return...

Coupang FY 2025 Results Set Up a Mixed but Margin Focused Story Coupang (CPNG) closed FY 2025 with fourth quarter revenue of US$8.8b and a basic EPS loss of US$0.01, as net income excluding extra items came in at a US$26m loss against a backdrop of growing full year scale. The company has seen quarterly revenue step up from US$7.9b in Q4 2024 to between US$7.9b and US$9.3b through 2025. Basic EPS has moved between a profit of US$0.06 and a small loss in the latest quarter, setting up a TTM...

If you are wondering whether Nova's share price still reflects good value after a strong run, this article is for you. We will walk through what the current market price might be implying about the business. Nova's stock last closed at US$438.86, with a 7 day return of a 0.5% decline, a 30 day return of a 9.9% decline, a year to date return of 26.3% and a 1 year return of 83.5%, while the 3 year return is very large and the 5 year return is also very large. Recent news coverage around Nova...

Opera (NasdaqGS:OPRA) posts FY 2025 results Opera (NasdaqGS:OPRA) closed out FY 2025 with fourth quarter revenue of US$176.7 million and basic EPS of US$0.62, rounding off a trailing twelve month run of US$614.4 million in revenue and EPS of US$1.21 as earnings grew 34.1% over the past year. The company has seen revenue move from US$480.6 million on a trailing basis at the end of 2024 to US$614.4 million by the end of 2025, while trailing net profit margin edged up from 16.8% to 17.6%. With...

ABM Industries, NYSE:ABM, is repositioning itself as a defensive, cash-focused services company. Management is prioritizing margin protection through wage inflation management and contract repricing. The company is reshaping its portfolio with selective divestitures and greater emphasis on technology-enabled services. ABM Industries, trading at $44.5, is presenting itself as a steadier, lower volatility option within the outsourced facilities and services space. The effort is playing out...

CRA International (CRAI) has drawn investor attention after recent share price moves, with the stock up 3.1% over the past week but showing negative returns over the past month and past 3 months. See our latest analysis for CRA International. That recent 3.1% one day share price gain sits against a weaker backdrop, with a 30 day share price return of 7.5% and a year to date share price return of a 13.9% decline. However, longer term total shareholder returns of 62% over three years and 178%...

Innodata (INOD) has just wrapped up FY 2025 with fourth quarter revenue of US$72.4 million and basic EPS of US$0.28, alongside trailing twelve month revenue of US$251.7 million and EPS of US$1.01. The company has seen quarterly revenue move from US$52.2 million in Q3 2024 to US$72.4 million in Q4 2025. Basic EPS has ranged from US$0.60 in Q3 2024 to between US$0.23 and US$0.28 across the 2025 quarters, setting up a picture where growing sales are rubbing against tighter margins and leaving...

If you are wondering whether SoFi Technologies shares are offering good value right now, you are not alone. This article will walk through what the current price actually reflects. The stock recently closed at US$17.76, with returns of a 6.6% decline over 7 days, a 27.8% decline over 30 days, a 35.3% decline year to date, but a 22.7% gain over 1 year and a very large gain over 3 years. These moves have come as SoFi remains a widely watched name in US fintech, with ongoing attention on its...

Eli Lilly (LLY) is back in focus after fresh clinical data showed its injectable GLP-1 drug tirzepatide and oral candidate orforglipron outperforming Novo Nordisk rivals in weight loss and blood sugar control. See our latest analysis for Eli Lilly. The latest tirzepatide and orforglipron data slot into a busy few weeks for Eli Lilly, with Zepbound’s new KwikPen format, expanded data across Omvoh and Taltz combinations, and regulatory progress for Olumiant helping keep attention on its obesity...

Assessing Pilgrim's Pride after recent share performance Pilgrim's Pride (PPC) has drawn fresh attention after a recent 4.1% daily gain and a 3.4% move over the past week, prompting investors to reassess the stock's recent return profile. See our latest analysis for Pilgrim's Pride. Looking past the latest move, Pilgrim's Pride has a 90 day share price return of 13.46% and a 3 year total shareholder return of 110.44%, which suggests recent momentum sits against a much stronger longer term...

In recent weeks, Alibaba Group Holding, through its cloud unit, launched a low-cost, multi-model AI coding subscription that bundles access to several leading Chinese open-source models, including its own Qwen 3.5, while also advancing its AI infrastructure with its self-developed Zhenwu 810E chip. This push into flexible, bundled AI tools signals a shift in Alibaba’s focus from its traditional e-commerce roots toward building a broader AI and cloud ecosystem for developers and...

If you are wondering whether Federal Home Loan Mortgage at around US$6.44 is still offering value after its big run in recent years, you are not alone. The stock has seen a 17.3% return over the past year, even after a 37.8% year to date decline, a 9.9% drop over 30 days and an 11.7% fall over the last week, so the price is still adjusting after a very large 3 year gain that is well over 10x. Recent coverage has focused on Federal Home Loan Mortgage as part of the broader conversation around...

On Holding (NYSE:ONON) is expanding rapidly across Asia-Pacific, adding new markets and strengthening its regional presence. The company is pushing its direct-to-consumer model globally, supported by its own performance footwear and apparel technology. Management is putting capital behind product development and customer engagement, with an eye on premium brand positioning worldwide. On Holding, trading at around $46.48, sits in a premium corner of the sportswear space with a 3 year return...

Teekay (TK) has been drawing attention after recent share price moves, with the stock showing strong returns over the past year and the past 3 months. Investors are weighing how this performance lines up with fundamentals. See our latest analysis for Teekay. With the share price at $12.95 and a 30 day share price return of 29.11% building on a 33.37% 90 day gain, the recent move continues a longer run in which the 1 year total shareholder return of 125.21% sits alongside a 5 year total...

Blackbaud, NasdaqGS:BLKB, has accelerated the rollout of artificial intelligence tools tailored to nonprofits. The company has launched its proprietary Agents for Good autonomous AI products, built on a philanthropic dataset. These AI tools focus on nonprofit fundraising and donor engagement, positioning Blackbaud differently from general large language models. For investors watching Blackbaud at a share price of $48.54, the new AI push arrives after a period of weaker stock performance...

In February 2026, Hayward Holdings, Inc. reported fourth-quarter 2025 sales of US$349.38 million and net income of US$68.41 million, with full-year 2025 sales reaching US$1.12 billion and net income of US$151.57 million, alongside higher basic and diluted earnings per share from continuing operations versus 2024. The company also issued 2026 guidance calling for around 4% net sales growth supported by margin improvement, technology adoption, and operational efficiencies, highlighting the...

Campbell Soup Company (NasdaqGS:CPB) has appointed Mohit Anand as Executive Vice President and President of its Snacks division. Anand joins to address challenges in the snacks unit, which has experienced sales declines. The appointment places an experienced food and beverage leader in charge of a key segment that the company has identified as a growth focus. For investors watching NasdaqGS:CPB, the snacks business matters because it sits alongside the company’s more mature soup and meals...

Catalyst Pharmaceuticals recently reported past fourth-quarter 2025 revenue of US$152.61 million and full-year revenue of US$588.99 million, alongside issuing 2026 guidance for total revenues of US$615 million to US$645 million and announcing a US$200 million share repurchase program. The results highlight how expanding adoption of FIRDAPSE and AGAMREE, combined with capital returns to shareholders, is reshaping Catalyst’s rare‑disease business profile. Next, we’ll examine how this new 2026...